BridgeMD
New treatment option for Hepatocellular Carcinoma
Official title FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.
ClinicalTrials.gov ID: NCT05095714
What this study is testing
- What it's testing
- Intro: Hepatocellular carcinoma (HCC) is the 6th leading cause of cancer worldwide. In France, more than 10,000 new cases are identified each year.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Patient enrolled in a screening program for at least 6 months in a tertiary hepatology center
- Cirrhosis histologically proven or unequivocally suggested by non-invasive tests
- Absence of HCC on imaging less than 3 months o
- Liver parenchyma explorable by ultrasound
You likely can't join if
- Child-Pugh C score
- Active hepatitis B or C
- Estimated annual risk of HCC\<3%
- No prior enrollment in a screening program
- Contraindication to Fast-MRI
- Non-echogenic patient
See the full eligibility criteria
- Age ≥ 18 years
- Patient enrolled in a screening program for at least 6 months in a tertiary hepatology center
- Cirrhosis histologically proven or unequivocally suggested by non-invasive tests
- Absence of HCC on imaging less than 3 months o
- Liver parenchyma explorable by ultrasound
- Child-Pugh A or B
- Cirrhosis of non-viral or viral B/C cause controlled/healed
- With an estimated annual risk of HCC\>3%
- Written informed consent
- Affiliation to a social security system
- Child-Pugh C score
- Active hepatitis B or C
- Estimated annual risk of HCC\<3%
- No prior enrollment in a screening program
- Contraindication to Fast-MRI
- Non-echogenic patient
- Patient deprived of liberty
- Patient under legal protection
- Pregnant or breastfeeding woman
- Patient on AME (state medical aid)
The study team makes the final eligibility decision.
Where it's taking place
- Bondy, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bondy, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.